Latest news with #CareCloud
Yahoo
02-06-2025
- Business
- Yahoo
CareCloud to Present on AI Innovation at Maxim Group's 2025 Virtual Tech Conference on June 3, 2025
Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ('CareCloud' or the 'Company'), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that its Co-Chief Executive Officers have been invited to participate in the '2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,' presented by Maxim Group LLC. The Healthcare IT Panel, featuring CareCloud, will take place on Tuesday, June 3, 2025, at 11:00 a.m. EDT. CareCloud will join the Healthcare IT Panel to share how artificial intelligence is transforming every facet of healthcare delivery—from clinical decision support and administrative automation to revenue optimization. The conference, hosted on M-Vest, will showcase how emerging growth companies are leveraging transformative technologies such as Quantum Computing and Artificial Intelligence ('AI') to position themselves for long-term success. Moderated by Maxim Group Senior Analysts, the event will include insightful conversations with CEOs and executive leaders driving innovation in their respective industries. To attend the conference and view CareCloud's presentation, participants must register as an M-Vest member. Click here to learn more and reserve your seat About CareCloud CareCloud (Nasdaq: CCLD, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at Follow CareCloud on LinkedIn, X and Facebook. For additional information, please visit our website at To listen to video presentations by CareCloud's management team, read recent press releases and view the latest investor presentation, please visit About Maxim Group LLC Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB) and is a member of FINRA SIPC, and NASDAQ. To learn more about Maxim Group, visit Disclaimer This press release is for information purposes only and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction. Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'might,' 'will,' 'shall,' 'should,' 'could', 'intends,' 'expects,' 'plans,' 'goals,' 'projects,' 'anticipates,' 'believes,' 'seeks,' 'estimates,' 'predicts,' 'possible,' 'potential,' 'target,' or 'continue' or the negative of these terms or other comparable terminology. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions. These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled 'Risk Factors' in the Company's filings with the Securities and Exchange Commission. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. SOURCE: CareCloud Company Contact: Norman Roth Interim Chief Financial Officer and Corporate Controller CareCloud, Inc. nroth@ Investor Contact: Stephen Snyder Co-Chief Executive Officer CareCloud, Inc. ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
CareCloud Announces Results from Annual Shareholders' Meeting
Shareholders Re-Elect 3 Board Members, Approve the Compensation for the Company's Named Executives and Approve the Appointment of Public Accounting Firm SOMERSET, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the 'Company') (Nasdaq: CCLD, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that it held its 2025 Annual Shareholders' Meeting on May 27, 2025, during which shareholders re-elected Anne Busquet, Bill Korn and Lawrence Sharnak for another two-year term. Shareholders also voted to approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's 2025 Proxy Statement's compensation tables and any related information found in such proxy statement and voted to approved the appointment of Rosenberg Rich Baker Berman, P.A. as the Company's independent registered public accounting firm for the year ending December 31, 2025. CareCloud's shareholders approved the following three proposals: Re-elect Anne Busquet, Bill Korn and Lawrence Sharnak to the Board of Directors. The compensation of the Company's named executive officers, on an advisory basis, as disclosed in the Company's Proxy Statement. The appointment of Rosenberg Rich Baker Berman, P.A. as our independent registered public accounting firm for the year ending December 31, 2025. CareCloud is proud to announce the re-appointment of Anne Busquet, Bill Korn and Lawrence Sharnak to the Board. Anne Busquet has over 30 years of executive business experience with American Express and Interactive Corp. Bill Korn served as our Chief Financial Officer for 10 years before retiring in October 2023. Lawrence Sharnak served at American Express for more than 30 years where he held a variety of senior leadership roles. 'We are pleased to announce the re-election of Anne, Bill and Larry,' said CareCloud's Co-CEO, Stephen Snyder. The final voting tallies from this year's Annual Meeting were included in a Form 8-K which was previously filed with the Securities and Exchange Commission. About CareCloud CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at To listen to video presentations by CareCloud's management team, read recent press releases and view the latest investor presentation, please visit Follow CareCloud on LinkedIn, X and Facebook. Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'might,' 'will,' 'shall,' 'should,' 'could', 'intends,' 'expects,' 'plans,' 'goals,' 'projects,' 'anticipates,' 'believes,' 'seeks,' 'estimates,' 'predicts,' 'possible,' 'potential,' 'target,' or 'continue' or the negative of these terms or other comparable terminology. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions. These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward- looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled 'Risk Factors' in the Company's filings with the Securities and Exchange Commission. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. SOURCE CareCloud Company Contact:Norman RothInterim Chief Financial Officer and Corporate ControllerCareCloud, Inc. nroth@ Investor Contact: Stephen Snyder Co-Chief Executive Officer CareCloud, Inc. ir@
Globe and Mail
25-05-2025
- Business
- Globe and Mail
CareCloud Delivers Growth and Strong Cash Flow in Q1 2025, Advances AI and Acquisition Strategy
SOMERSET, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the three months ended March 31, 2025. CareCloud's strategic execution, AI-driven innovation, and disciplined financial management have fueled a transformational turnaround, positioning the Company for sustained profitability and long-term growth. Management will discuss these results and the Company's 2025 growth strategies in a live conference call today at 8:30 a.m. ET. First Quarter 2025 Financial Highlights: Revenue of $27.6 million, compared to $26.0 million in Q1 2024, an increase of 6% year-over-year GAAP net income of $1.9 million, compared to a net loss of $241,000 in Q1 2024 Adjusted EBITDA of $5.6 million, compared to $3.7 million in Q1 2024, an increase of 52% Adjusted net income of $2.3 million, or $0.05 per share Cash balance of $6.8 million and net working capital of $11.7 million as of March 31, 2025 Recent Strategic Updates AI Center of Excellence Launched: CareCloud launched its dedicated AI Center of Excellence, onboarding the first wave of over 50 AI professionals and aiming to scale to 500 AI specialists by fourth quarter 2025. The initiative is fully self-funded through operating cash flows. Series A Preferred Stock Conversion Completed: Successfully converted 3.5 million Series A preferred shares into 26 million common shares, reducing the annual dividend commitment by approximately $7.7 million and strengthening cash flow and the capital structure. Resumption of Preferred Dividends: Payments of preferred dividends resumed in February 2025. Acquisition Strategy Reignited: Completed two strategic acquisitions in March and April 2025, with additional acquisition opportunities actively under evaluation. Management Commentary: "The launch of our AI Center of Excellence marks a pivotal moment in CareCloud's evolution," said A. Hadi Chaudhry, Co-CEO of CareCloud. "By building one of the largest dedicated healthcare AI teams globally, we believe we are creating real-world solutions to automate clinical workflows, optimize revenue cycle management, and improve patient outcomes. This initiative is intended to accelerate our operational efficiency as well as positioning CareCloud at the forefront of intelligent healthcare transformation — driving sustainable profitability and long-term growth for ourselves and the healthcare providers who use our services." 'After record profits and a successful turnaround in 2024, we are excited to announce continued momentum and strength as we enter 2025,' said Co-CEO Stephen Snyder. 'With two recent acquisitions and the launch of our AI Center of Excellence, CareCloud is not just responding to the market shift — we are intending to lead it.' 'We are pleased to announce our fourth consecutive quarter of positive GAAP net income and an increase in revenue and adjusted EBITDA year over year,' said Norman Roth, Interim CFO and Corporate Controller of CareCloud. 'We have resumed paying our Preferred Stock dividends monthly out of internally-generated free cash flow, while generating additional profits and cash flow to reinvest for future growth. To date we have declared six months of Preferred Stock dividends.' Capital On March 31, 2025, the Company had 984,530 shares of Series A Preferred Stock and 1,511,372 shares of non-convertible Series B Preferred Stock outstanding. As of March 31, 2025, the Series A and B shares both accrued dividends at the rate of 8.75% per annum, based on the $25.00 per share liquidation preference (equivalent to $2.1875 annually per share), and they are redeemable at the Company's option once the preferred stock dividends are brought current. 2025 Guidance: Poised for Growth CareCloud is reconfirming its earnings guidance for 2025, expecting: For the Fiscal Year Ending December 31, 2025 Forward-Looking Guidance Revenue $111 – $114 million Adjusted EBITDA $26 – $28 million Net Income Per Share (EPS) $0.10 - $0.13 The Company continues to anticipate full year 2025 revenue of approximately $111 to $114 million. Revenue guidance is based on management's expectations regarding revenue from existing clients, organic growth in new client additions and anticipated number of small tuck-in acquisitions. Adjusted EBITDA is expected to be $26 to $28 million for full year 2025 and reflects improvements from the Company's cost reduction efforts. EPS is expected to be $0.10 to $0.13 for full year 2025. Conference Call Information CareCloud management will host a conference call today at 8:30 a.m. Eastern Time to discuss the first three months of 2025 results. The live webcast of the conference call and related presentation slides can be accessed at An audio-only option is available by dialing 201-389-0920 and referencing 'CareCloud First Quarter 2025 Results Conference Call.' Investors who opt for audio-only will need to download the related slides at A replay of the conference call and related presentation slides will be available approximately three hours after conclusion of the call at the same link. An audio-only option can also be accessed by dialing 412-317-6671 and providing the access code 13753440. Use of Non-GAAP Financial Measures In our earnings releases, prepared remarks, conference calls, slide presentations, and webcasts, we use and discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at Forward-Looking Statements This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'might,' 'will,' 'shall,' 'should,' 'could,' 'intends,' 'expects,' 'plans,' 'goals,' 'projects,' 'anticipates,' 'believes,' 'seeks,' 'estimates,' 'forecasts,' 'predicts,' 'possible,' 'potential,' 'target,' or 'continue' or the negative of these terms or other comparable terminology. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions. These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies' products and services competitive with ours, manage and keep our information systems secure and other important risks and uncertainties referenced and discussed under the heading titled 'Risk Factors' in the Company's filings with the Securities and Exchange Commission. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. About CareCloud CareCloud (Nasdaq: CCLD, CCLDO) brings disciplined innovation and generative AI solutions to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), artificial intelligence (AI), business intelligence (BI), patient experience management (PXM) and digital health, at Follow CareCloud on LinkedIn, X and Facebook. For additional information, please visit our website at To listen to video presentations by CareCloud's management team, read recent press releases and view the latest investor presentation, please visit SOURCE CareCloud CARECLOUD, INC. CONDENSED CONSOLIDATED BALANCE SHEETS ($ in thousands, except share and per share amounts) March 31, December 31, 2025 2024 (Unaudited) ASSETS Current assets: Cash $ 6,805 $ 5,145 Accounts receivable - net 13,887 12,774 Contract asset 4,457 4,334 Inventory 609 574 Current assets - related party 16 16 Prepaid expenses and other current assets 2,843 1,957 Total current assets 28,617 24,800 Property and equipment - net 5,323 5,290 Operating lease right-of-use assets 3,097 3,133 Intangible assets - net 16,877 18,698 Goodwill 19,186 19,186 Other assets 456 507 TOTAL ASSETS $ 73,556 $ 71,614 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 4,951 $ 4,565 Accrued compensation 2,865 1,817 Accrued expenses 5,002 4,951 Operating lease liability (current portion) 1,355 1,287 Deferred revenue (current portion) 1,297 1,212 Notes payable (current portion) 133 310 Contingent consideration (current portion) 47 - Dividend payable 1,299 5,438 Total current liabilities 16,949 19,580 Notes payable 23 26 Contingent consideration 60 - Operating lease liability 1,776 1,847 Deferred revenue 571 387 Total liabilities 19,379 21,840 COMMITMENTS AND CONTINGENCIES SHAREHOLDERS' EQUITY: Preferred stock, $0.001 par value - authorized 7,000,000 shares. Series A, issued and outstanding 984,530 and 4,526,231 shares at March 31, 2025 and December 31, 2024, respectively. Series B, issued and outstanding 1,511,372 shares at March 31, 2025 and December 31, 2024. 2 6 Common stock, $0.001 par value - authorized 85,000,000 shares. Issued 43,061,928 and 16,997,035 shares at March 31, 2025 and December 31, 2024, respectively. Outstanding 42,321,129 and 16,256,236 shares at March 31, 2025 and December 31, 2024, respectively 43 17 Additional paid-in capital 123,537 121,046 Accumulated deficit (64,682) (66,630) Accumulated other comprehensive loss (4,061) (4,003) Less: 740,799 common shares held in treasury, at cost at March 31, 2025 and December 31, 2024 (662) (662) Total shareholders' equity 54,177 49,774 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 73,556 $ 71,614 CARECLOUD, INC. FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024 ($ in thousands, except share and per share amounts) Three Months Ended March 31, 2025 2024* NET REVENUE $ 27,632 $ 25,962 OPERATING EXPENSES: Direct operating costs 15,464 15,177 Selling and marketing 1,131 1,770 General and administrative 4,332 3,721 Research and development 1,235 913 Depreciation and amortization 3,337 3,930 Restructuring costs 114 322 Total operating expenses 25,613 25,833 OPERATING INCOME 2,019 129 OTHER: Interest income 42 27 Interest expense (58) (365) Other (expense) income - net (14) 7 INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES 1,989 (202) Income tax provision 41 39 NET INCOME (LOSS) $ 1,948 $ (241) Preferred stock dividend 2,811 1,312 NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (863) $ (1,553) Net loss per common share: basic and diluted $ (0.04) $ (0.10) Weighted-average common shares used to compute basic and diluted loss per share 23,813,943 16,014,309 * Restated to include the preferred stock dividends earned, but not declared, during the three months ended March 31, 2024. CARECLOUD, INC. FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024 ($ in thousands) 2025 2024 OPERATING ACTIVITIES: Net income (loss) $ 1,948 $ (241) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 3,407 4,020 Lease amortization 480 509 Deferred revenue 269 58 Provision for expected credit losses 70 37 Foreign exchange gain (1) (11) Interest accretion 107 168 Stock-based compensation expense (benefit) 108 (708) Changes in operating assets and liabilities: Accounts receivable (1,183) (111) Contract asset (105) (361) Inventory (35) (15) Other assets (908) - Accounts payable and other liabilities 956 721 Net cash provided by operating activities 5,113 4,066 INVESTING ACTIVITIES: Purchases of property and equipment (624) (298) Capitalized software and other intangible assets (846) (1,570) Initial payment for acquisition (40) - Net cash used in investing activities (1,510) (1,868) FINANCING ACTIVITIES: Preferred stock dividends paid (1,730) - Settlement of tax withholding obligations on stock issued to employees (21) (151) Repayments of notes payable (181) (223) Repayment of line of credit - (1,000) Net cash used in financing activities (1,932) (1,374) EFFECT OF EXCHANGE RATE CHANGES ON CASH (11) (17) NET INCREASE IN CASH 1,660 807 CASH - Beginning of the period 5,145 3,331 CASH - End of the period $ 6,805 $ 4,138 SUPPLEMENTAL NONCASH INVESTING AND FINANCING ACTIVITIES: Conversion of preferred stock and accrued dividends to common stock $ 2,435 $ - Dividends declared, not paid $ 1,299 $ 5 Purchase of prepaid insurance with assumption of note $ - $ 96 Reclass of deposits for property and equipment placed in service $ - $ 296 SUPPLEMENTAL INFORMATION - Cash paid during the period for: Income taxes $ 15 $ 6 Interest $ 18 $ 295 RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO COMPARABLE GAAP MEASURES The following is a reconciliation of the non-GAAP financial measures used by us to describe our financial results determined in accordance with accounting principles generally accepted in the United States of America ('GAAP'). An explanation of these measures is also included below under the heading 'Explanation of Non-GAAP Financial Measures.' While management believes that these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying performance of our business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Adjusted EBITDA to GAAP Net Income (Loss) Set forth below is a reconciliation of our 'adjusted EBITDA' to our GAAP net income (loss). Non-GAAP Adjusted Operating Income to GAAP Operating Income Set forth below is a reconciliation of our non-GAAP 'adjusted operating income' and non-GAAP 'adjusted operating margin' to our GAAP operating income and GAAP operating margin. Three Months Ended March 31, 2025 2024 ($ in thousands) Net revenue $ 27,632 $ 25,962 GAAP net income (loss) 1,948 (241) Provision for income taxes 41 39 Net interest expense 16 338 Other expense (income) - net 14 (7) GAAP operating income 2,019 129 GAAP operating margin 7.3 % 0.5 % Stock-based compensation expense (benefit) 108 (708) Amortization of purchased intangible assets 89 840 Transaction and integration costs 12 12 Restructuring costs 114 322 Non-GAAP adjusted operating income $ 2,342 $ 595 Non-GAAP adjusted operating margin 8.5 % 2.3 % Non-GAAP Adjusted Net Income to GAAP Net Income (Loss) Set forth below is a reconciliation of our non-GAAP 'adjusted net income' and non-GAAP 'adjusted net income per share' to our GAAP net income (loss) and GAAP net loss per share. Three Months Ended March 31, 2025 2024 ($ in thousands) GAAP net income (loss) $ 1,948 $ (241) Foreign exchange loss (gain) / other expense 19 (5) Stock-based compensation expense (benefit) 108 (708) Amortization of purchased intangible assets 89 840 Transaction and integration costs 12 12 Restructuring costs 114 322 Non-GAAP adjusted net income $ 2,290 $ 220 End-of-period common shares 42,321,129 16,118,492 Non-GAAP adjusted net income per share $ 0.05 $ 0.01 For purposes of determining non-GAAP adjusted net income per share, we used the number of common shares outstanding as of March 31, 2025 and 2024. Three Months Ended March 31, 2025 2024 GAAP net loss attributable to common shareholders, per share $ (0.04) $ (0.10) Impact of preferred stock dividend 0.09 0.08 Net income (loss) per end-of-period share 0.05 (0.02) Foreign exchange loss (gain) / other expense 0.00 0.00 Stock-based compensation expense (benefit) 0.00 (0.04) Amortization of purchased intangible assets 0.00 0.05 Transaction and integration costs 0.00 0.00 Restructuring costs 0.00 0.02 Non-GAAP adjusted earnings per share $ 0.05 $ 0.01 Net cash provided by operating activities to free cash flow Set forth below is a reconciliation of our non-GAAP 'free cash flow' to our GAAP net cash provided by operating activities. Three Months Ended March 31, 2025 2024 ($ in thousands) Net cash provided by operating activities $ 5,113 $ 4,066 Purchases of property and equipment (624) (298) Capitalized software and other intangible assets (846) (1,570) Free cash flow $ 3,643 $ 2,198 Net cash used in investing activities 1 $ (1,510) $ (1,868) Net cash used in financing activities $ (1,932) $ (1,374) 1 Net cash used in investing activities includes purchases of property and equipment and capitalized software and other intangible assets, which are also included in our computation of free cash flow. Explanation of Non-GAAP Financial Measures We report our financial results in accordance with accounting principles generally accepted in the United States of America, or GAAP. However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management also uses results of operations before such items to evaluate the operating performance of CareCloud and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. Management uses adjusted EBITDA, adjusted operating income, adjusted operating margin, and non-GAAP adjusted net income to provide an understanding of aspects of operating results before the impact of investing and financing charges and income taxes. Adjusted EBITDA may be useful to an investor in evaluating our operating performance and liquidity because this measure excludes non-cash expenses as well as expenses pertaining to investing or financing transactions. Management defines 'adjusted EBITDA' as the sum of GAAP net income (loss) before provision for income taxes, net interest expense, foreign exchange loss (gain) / other expense, stock-based compensation expense (benefit), depreciation and amortization, transaction and integration costs, and restructuring costs. Management defines 'non-GAAP adjusted operating income' as the sum of GAAP operating income before stock-based compensation expense (benefit), amortization of purchased intangible assets, transaction and integration costs, and restructuring costs, and 'non-GAAP adjusted operating margin' as non-GAAP adjusted operating income divided by net revenue. Management defines 'non-GAAP adjusted net income' as the sum of GAAP net income (loss) before foreign exchange loss (gain) / other expense, stock-based compensation expense (benefit), amortization of purchased intangible assets, transaction and integration costs, and restructuring costs, and 'non-GAAP adjusted net income per share' as non-GAAP adjusted net income divided by common shares outstanding at the end of the period. Management defines 'free cash flow' as the sum of net cash provided by operating activities less cash used for purchases of property and equipment and cash used to develop capitalized software and other intangible assets. Management considers all of these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance. In addition to items routinely excluded from non-GAAP EBITDA, management excludes or adjusts each of the items identified below from the applicable non-GAAP financial measure referenced above for the reasons set forth with respect to that excluded item: Foreign exchange loss (gain) / other expense. Other expense is excluded because foreign currency gains and losses and other non-operating expenses are expenditures that management does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount of the expense is partially outside of our control. Foreign currency gains and losses are based on global market factors which are unrelated to our performance during the period in which the gains and losses are recorded. Stock-based compensation expense (benefit). Stock-based compensation expense (benefit) is excluded because this is primarily a non-cash expenditure that management does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount of the expenditure is partially outside of our control because it is based on factors such as stock price, volatility, and interest rates, which may be unrelated to our performance during the period in which the expenses are incurred. Stock-based compensation expense includes cash-settled awards based on changes in the stock price. Amortization of purchased intangible assets. Purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are recorded. Transaction costs. Transaction costs are upfront costs related to acquisitions and related transactions, such as brokerage fees, pre-acquisition accounting costs and legal fees, and other upfront costs related to specific transactions. Management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred. Integration costs. Integration costs are severance payments for certain employees relating to our acquisitions and exit costs related to terminating leases and other contractual agreements. Accordingly, management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred. Restructuring costs. Restructuring costs primarily consist of severance and separation costs associated with the optimization of the Company's operations and profitability improvements. Management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred. Free cash flow. Management believes that free cash flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company's financial performance. Free cash flow should be considered in addition to, rather than as a substitute for, consolidated net operating results as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, the Company's definition of free cash flow is limited, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct the payments required for debt service and other contractual obligations or payments made for business acquisitions. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our condensed consolidated statements of cash flows.
Yahoo
17-04-2025
- Business
- Yahoo
CareCloud to Announce First Quarter 2025 Results on May 6, 2025
SOMERSET, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the first quarter ended March 31, 2025 before the market opens on Tuesday, May 6, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at An audio-only option is available by dialing 201-389-0920 and referencing 'CareCloud First Quarter 2025 Results Conference Call.' Investors who opt for audio-only will need to download the related slides at A replay of the conference call and related presentation slides will be available approximately three hours after conclusion of the call at the same link. An audio-only option can also be accessed by dialing 412-317-6671 and providing the access code 13753440. About CareCloud CareCloud (Nasdaq: CCLD, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at Follow CareCloud on LinkedIn, X and Facebook. For additional information, please visit our website at To listen to video presentations by CareCloud's management team, read recent press releases and view the latest investor presentation, please visit SOURCE CareCloud Company Contact:Norman RothInterim Chief Financial Officer and Corporate ControllerCareCloud, Investor Contact:Stephen SnyderCo-Chief Executive OfficerCareCloud, in to access your portfolio
Yahoo
27-03-2025
- Business
- Yahoo
Alpine ENT adopts CareCloud's FrontDesk Assist solution
Alpine Ear, Nose & Throat (Alpine ENT) has implemented the CareCloud FrontDesk Assist front-office solution after a revenue cycle management (RCM) collaboration. Alpine ENT is a US-based otolaryngology group. The solution is designed for streamlining operations and improving patient satisfaction. Alpine ENT CEO Mike Heck said: 'CareCloud has proven to be a true partner in optimising our practice. 'Since deploying FrontDesk Assist, we've seen tangible improvements across our front-desk operations. Patient wait times are shorter, appointment scheduling is smoother, and our staff now spends far less time on administrative tasks.' FrontDesk Assist enhances critical functions, such as referral management and prior authorisations, complementing the RCM services that are already in place. The solution is also helpful in appointment scheduling and surgery estimates. With a team of 24 care providers in three locations in Northern Colorado, Alpine ENT offers a comprehensive range of services, encompassing audiology and allergy care. The adoption of FrontDesk Assist has led to increased productivity and patient engagement, facilitating quality care. CareCloud president Crystal Williams said: 'Alpine ENT's decision to expand our collaboration speaks to the trust they place in CareCloud's expertise and solutions. 'With FrontDesk Assist, they gain a seamlessly integrated platform that drives both financial and patient-centered outcomes. Our mission is to simplify practice operations so providers can focus on delivering exceptional care.' The expansion of services underscores CareCloud's focus on providing scalable, technology-driven solutions that support healthcare organisations in a rapidly evolving industry. FrontDesk Assist is now offered to healthcare practices across the US, catering to various specialties. In January last year, CareCloud's practice management platform, CareCloud Central, was implemented by pathology practice siParadigm to improve operational efficiency and patient care quality. Prior to this, in July 2023, CareCloud partnered with Google Cloud to incorporate generative AI into its offerings, aiming to enhance the efficiency of ambulatory practices in office settings. "Alpine ENT adopts CareCloud's FrontDesk Assist solution" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
